Triple therapy for atrial fibrillation and percutaneous coronary intervention

Naoual Bennaghmouch1, Willem J M Dewilde, Jurrien M ten Berg

  • 1aDepartment of Cardiology, St Antonius Hospital, Nieuwegein bDepartment of Cardiology, Amphia Hospital Breda, the Netherlands.

Insights

For atrial fibrillation patients undergoing percutaneous coronary intervention (PCI), new strategies reduce bleeding risks. Omitting aspirin and using proton pump inhibitors after PCI improve safety of antithrombotic treatment.

Area of Science:

  • Cardiology
  • Pharmacology
  • Interventional Cardiology

Background:

  • Patients with atrial fibrillation undergoing percutaneous coronary intervention (PCI) often require triple therapy (oral anticoagulation plus dual antiplatelet therapy).
  • This triple therapy carries a high annual bleeding risk, often outweighing its benefits.
  • Optimizing antithrombotic treatment is crucial for improving patient safety.

Purpose of the Study:

  • To review current guidelines and emerging evidence for optimizing antithrombotic treatment in atrial fibrillation patients requiring oral anticoagulation and dual antiplatelet therapy.
  • To evaluate the risks and benefits of various treatment options to enhance safety.
  • To provide an overview of strategies for combined OAC and DAPT treatment.

Main Methods:

  • Literature review of current guidelines and new evidence.
  • Analysis of strategies to reduce bleeding risk during and after PCI.
  • Evaluation of different antithrombotic regimens.

Main Results:

  • Uninterrupted anticoagulation, radial access, and newer-generation drug-eluting stents are preferred for reducing bleeding during PCI.
  • Glycoprotein receptor inhibitors should be avoided post-PCI.
  • Omitting aspirin and using proton pump inhibitors after PCI significantly reduces bleeding risk compared to traditional triple therapy.

Conclusions:

  • Newer strategies for antithrombotic treatment show promise in improving safety for atrial fibrillation patients undergoing PCI.
  • These approaches aim to balance the need for antithrombotic efficacy with a reduced risk of bleeding.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
418
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
583
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
467
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
522
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
583
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
466